COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 125 filers reported holding COHERUS BIOSCIENCES INC in Q4 2016. The put-call ratio across all filers is 4.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $727,163 | +100.7% | 420,326 | +177.3% | 0.00% | 0.0% |
| Q1 2024 | $362,236 | -7.2% | 151,563 | +29.3% | 0.00% | 0.0% |
| Q4 2023 | $390,209 | -95.5% | 117,180 | -94.9% | 0.00% | -94.4% |
| Q3 2023 | $8,647,652 | -11.3% | 2,312,206 | +1.3% | 0.02% | -5.3% |
| Q2 2023 | $9,750,078 | +148.8% | 2,283,391 | +298.5% | 0.02% | +137.5% |
| Q1 2023 | $3,918,828 | +1232.9% | 572,928 | +1776.4% | 0.01% | +700.0% |
| Q3 2022 | $294,000 | -41.8% | 30,534 | -11.8% | 0.00% | -50.0% |
| Q1 2021 | $505,000 | +144.0% | 34,610 | +270.6% | 0.00% | 0.0% |
| Q2 2019 | $207,000 | -97.4% | 9,339 | -98.0% | 0.00% | -93.9% |
| Q3 2018 | $7,828,000 | +2021.4% | 474,364 | +1699.7% | 0.03% | +450.0% |
| Q2 2018 | $369,000 | -63.9% | 26,358 | -27.4% | 0.01% | -14.3% |
| Q4 2016 | $1,022,000 | – | 36,303 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,446,000 | 2.17% |
| CM Management, LLC | 125,000 | $2,009,000 | 1.50% |
| Bridge City Capital, LLC | 163,210 | $2,623,000 | 1.19% |
| Perceptive Advisors | 4,779,387 | $76,805,000 | 1.12% |
| Phocas Financial Corp. | 504,936 | $8,114,000 | 1.03% |
| Redwood Investments, LLC | 716,531 | $11,515,000 | 0.96% |
| Aristotle Capital Boston, LLC | 2,155,221 | $34,634,000 | 0.81% |
| KNOTT DAVID M | 102,555 | $1,648,000 | 0.60% |
| Zebra Capital Management LLC | 22,918 | $368,000 | 0.45% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $118,615,000 | 0.42% |